Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally

•There is urgency to act to limit the indirect effects of the COVID-19 pandemic on people with diabetes.•We aimed to identify the extent of these impacts and practical solutions that could improve clinical services.•The pandemic has major adverse indirect impacts.. However, several practical solutio...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2024-06, Vol.212, p.111693-111693, Article 111693
Main Authors: Rutter, Martin K., Carr, Matthew J., Wright, Alison K., Kanumilli, Naresh, Milne, Nicola, Jones, Ewan, Elton, Peter, Ceriello, Antonio, Misra, Anoop, Del Prato, Stefano, Barron, Emma, Hambling, Clare, Sattar, Naveed, Khunti, Kamlesh, Valabhji, Jonathan, Feldman, Eva L., Ashcroft, Darren M.
Format: Article
Language:English
Subjects:
Covid-19
Diabetes
Diagnosis
Monitoring
Prescribing
Service recovery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•There is urgency to act to limit the indirect effects of the COVID-19 pandemic on people with diabetes.•We aimed to identify the extent of these impacts and practical solutions that could improve clinical services.•The pandemic has major adverse indirect impacts.. However, several practical solutions where identified.•Healthcare teams may be able to take advantage of new ways of working to improve the lives of people with diabetes. The COVID-19 pandemic has caused major disruptions in clinical services for people with chronic long-term conditions. In this narrative review, we assess the indirect impacts of the COVID-19 pandemic on diabetes services globally and the resulting adverse effects on rates of diagnosing, monitoring, and prescribing in people with type 2 diabetes. We summarise potential practical approaches that could address these issues and improve clinical services and outcomes for people living with diabetes during the recovery phase of the pandemic.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2024.111693